Article
Sherlock Bio raises $80 million to develop CRISPR-based diagnostics
Rating:
0.0
Views:
49
Likes:
1
Library:
1
Sherlock Biosciences said on Tuesday it had raised $80 million in new funding to help bolster sales of its CRISPR-based COVID-19 test and develop new diagnostics based on the breakthrough gene editing technology.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value